Global Health

Global Health

1,299.70
-29.00
(-2.18%)
Market Cap
34,908.30 Cr
EPS
17.92
PE Ratio
61.28
Dividend Yield
0.00 %
52 Week High
1,456.50
52 Week Low
935.50
PB Ratio
10.32
Debt to Equity
0.24
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+63.64 %
+63.64 %
Hold
Hold+18.18 %
+18.18 %
Sell
Sell+18.18 %
+18.18 %

Company News

View All News
Caret
positive
Global Health Limited has received in-principle approval from Assam Industrial Development Corporation Limited for the allotment of 3.5 acres of land in Guwahati, Assam for a proposed hospital. The land is allotted for 60 years, extendable by 30 years, subject to compliance with conditions including remaining payment within 3 months. The company has paid 10% of the total payment as application money and received the approval letter dated September 03, 2025. The land is located at Industrial Estate, Sarusajai, Guwahati, Assam and measures 14,164.50 square meters. Management is working on next steps and will update exchanges and investors on material developments.
positive
Global Health Limited (Medanta) reported total income of INR 10,513 million for Q1 FY2026, representing 19% year-on-year growth from INR 8,830 million. EBITDA increased 23% to INR 2,553 million with an improved margin of 24.3%. Profit after tax surged 50% to INR 1,590 million, with PAT margin improving to 15.1% from 12%. The company showed strong operational metrics with inpatient volumes up 14%, outpatient volumes up 13%, and average occupied bed days increasing 13%. International patient revenues grew 34% to INR 636 million. The company operationalized a new 110-bed hospital in Ranchi and plans to commence operations at its 550-bed Noida facility. Mature hospitals achieved 62% occupancy with ARPOB growing 9% to INR 73,256, while developing hospitals in Lucknow and Patna maintained 64% occupancy. The company onboarded over 150 doctors including 30 senior clinicians and continues expansion with plans to add 2,000 beds over 3-4 years.
positive
Global Health has announced plans to invest ₹4,000 crore for expansion and growth initiatives. The investment will focus on adding 3,000 hospital beds to increase capacity. The company aims to double its EBITDA by FY30 as part of its growth strategy.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,123.40
#1 1,09,211.00
91.03
7,184.10
#1 28.68
1,076
30.34
38.75
7,510.00
1,07,982.30
68.57
#1 21,994.30
14.76
#1 1,505
39.78
42.87
932.75
70,418.70
76.18
7,849.70
13.25
809
#1 53.33
50.92
1,725.00
35,252.20
#1 44.56
5,575.00
12.29
790
-2.38
39.23
1,299.70
#5 34,908.30
#4 61.28
#6 3,771.40
#9 12.59
#5 481
#2 49.58
43.43
625.10
32,387.70
90.59
4,286.70
15.12
337
-98.18
58.09
726.70
29,078.10
78.90
3,067.00
21.98
415
-10.71
45.36
1,361.80
13,829.30
53.71
1,566.90
17.46
244
35.52
24.06
1,510.40
9,903.10
51.34
1,290.20
17.77
194
-1.57
70.90
647.40
9,025.80
244.98
2,257.70
17.03
49
-55.88
46.29
Forecast
Actual
Growth Rate
Revenue Growth
12.59 %
Net Income Growth
0.67 %
Cash Flow Change
1.91 %
ROE
-13.62 %
ROCE
-9.67 %
EBITDA Margin (Avg.)
-2.80 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
492
588
593
533
627
695
706
732
795
865
855
836
883
975
960
954
1,051
Expenses
386
442
448
441
485
523
534
540
595
631
621
629
675
728
706
757
784
EBITDA
106
146
146
92
142
172
172
192
199
234
234
207
208
247
254
198
267
Operating Profit %
21 %
24 %
23 %
15 %
21 %
23 %
23 %
24 %
24 %
25 %
26 %
22 %
22 %
24 %
25 %
19 %
24 %
Depreciation
31
31
33
35
36
37
39
38
40
43
44
46
47
49
49
49
45
Interest
16
17
18
28
19
18
21
21
18
20
18
18
18
16
16
15
14
Profit Before Tax
58
98
95
29
87
117
112
133
141
171
172
143
144
181
189
133
208
Tax
16
31
25
12
28
31
32
32
39
45
49
16
37
50
46
32
49
Net Profit
42
67
70
18
59
86
81
101
102
125
124
127
106
131
143
101
159
EPS in ₹
5.13
13.22
2.76
0.69
2.32
3.38
3.08
3.77
3.80
4.66
4.61
4.74
3.96
4.87
5.32
3.77
5.92

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,984
2,430
2,666
2,694
3,146
4,116
4,304
4,766
Fixed Assets
1,094
1,194
1,703
1,616
1,776
2,050
2,236
2,514
Current Assets
472
489
479
502
812
1,580
1,509
1,533
Capital Work in Progress
317
666
382
464
439
327
388
533
Investments
0
0
0
0
0
0
0
3
Other Assets
573
570
582
615
930
1,739
1,681
1,716
Total Liabilities
1,984
2,430
2,666
2,694
3,146
4,116
4,304
4,766
Current Liabilities
334
296
358
405
420
573
618
619
Non Current Liabilities
432
839
959
907
1,110
1,115
781
760
Total Equity
1,217
1,296
1,350
1,382
1,616
2,428
2,906
3,388
Reserve & Surplus
1,136
1,214
1,268
1,300
1,565
2,375
2,852
3,333
Share Capital
81
49
49
50
51
54
54
54

Cash Flow

Cash Flow
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-20
3
14
87
-78
50
648
-343
-194
Investing Activities
-126
-241
-69
-249
-87
-239
-421
-342
-441
-721
Operating Activities
213
228
63
166
175
242
311
645
612
624
Financing Activities
-88
-7
9
97
-1
-81
160
346
-514
-97

Share Holding

% Holding
Sept 2021
Oct 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
35.04 %
35.03 %
33.08 %
33.08 %
33.08 %
33.07 %
33.06 %
33.05 %
33.04 %
33.04 %
33.04 %
33.03 %
33.03 %
33.01 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.69 %
0.00 %
12.09 %
12.94 %
12.20 %
12.47 %
11.76 %
11.54 %
DIIs
0.00 %
0.00 %
7.78 %
12.55 %
12.35 %
10.80 %
10.93 %
9.68 %
10.25 %
10.57 %
11.11 %
10.51 %
11.93 %
12.20 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
25.44 %
6.16 %
5.77 %
6.79 %
6.85 %
6.79 %
7.14 %
6.28 %
6.54 %
6.74 %
6.53 %
6.48 %
Others
64.96 %
64.97 %
33.69 %
48.21 %
48.80 %
49.34 %
38.48 %
50.48 %
37.47 %
37.16 %
37.10 %
37.24 %
36.75 %
36.77 %
No of Share Holders
47
48
2,86,944
1,21,407
1,07,120
1,09,798
1,16,627
1,24,775
1,66,253
1,55,307
1,49,722
1,48,633
1,54,688
1,56,372

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Aug 2024 1,306.70 1,209.25
19 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2024 1,191.50 1,113.90
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 1,073.35 1,032.55
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,001.20 1,042.50
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 1,203.60 1,241.80
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 1,355.40 1,339.10
22 Aug 2025 DIVIDEND Dividend
₹ 0.50 /share
22 Aug 2025 1,241.80 1,389.30
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 1,339.10 1,367.70

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Closure of Trading Window3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report8 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Announcement Under Regulation 30 Of Listing RegulationsSep 04, 2025
Announcement Under Regulation 30 Of Listing RegulationsSep 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Letter To Shareholders Providing The Weblink Of Annual Report For The FY 2024-25Aug 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 25, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 25, 2025
Notice Of 21St Annual General Meeting Scheduled To Be Held On Friday September 19 2025 Through Video Conferencing (VC)/ OAVM For The Financial Year 2024-25.Aug 25, 2025
Reg. 34 (1) Annual Report.Aug 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendAug 07, 2025
Fixation Of Record Date For Declaration Of DividendAug 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 07, 2025
Results For The Quarter Ended June 30 2025Aug 07, 2025
Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing RegulationAug 07, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 02, 2025
Board Meeting Intimation for Intimation Under Regulation 29 Of Listing RegulationsJul 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 24, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Jul 24, 2025
Intimation Under Regulation 30 Of The Listing Regulations.Jul 23, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Closure of Trading WindowJun 27, 2025

Technical Indicators

RSI(14)
Neutral
37.79
ATR(14)
Volatile
35.46
STOCH(9,6)
Neutral
22.17
STOCH RSI(14)
Oversold
10.13
MACD(12,26)
Bearish
-8.47
ADX(14)
Weak Trend
19.38
UO(9)
Bearish
36.56
ROC(12)
Downtrend And Accelerating
-5.17
WillR(14)
Oversold
-85.96

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
UTI Mid Cap Fund Direct-Growth
0.17%
142610
0.17%
0.17%
Canara Robeco Large and Mid Cap Fund Direct-Growth
1.25%
127964
0.13%
0.30%
UTI Flexi Cap Fund Direct-Growth
1.50%
111095
0.14%
0.37%
360 ONE FlexiCap Fund Direct - Growth
1.40%
57693
0.44%
0.53%
Invesco India Mid Cap Fund Direct-Growth
3.05%
39848
0.11%
0.54%
PGIM India Small Cap Fund Direct - Growth
1.94%
-32356
-0.15%
0.10%
ITI Large & Mid Cap Fund Direct-Growth
0.45%
27281
0.45%
0.45%
Motilal Oswal Quant Fund Direct-Growth
1.20%
12170
1.20%
1.20%
Navi Large & Midcap Fund Direct-Growth
0.53%
12000
0.53%
0.53%
360 ONE Balanced Hybrid Fund Direct - Growth
0.57%
4969
0.11%
0.17%
WhiteOak Capital Quality Equity Fund Direct-Growth
1.42%
4094
0.10%
0.40%
Motilal Oswal Nifty Midcap 150 Index Fund Direct - Growth
0.34%
2413
0.02%
0.07%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.34%
2081
0.34%
0.34%
UTI India Consumer Fund Direct-Growth
1.31%
-1340
0.00%
0.30%
Nippon India Nifty Midcap 150 Index Fund Direct - Growth
0.34%
1303
0.03%
0.08%
WhiteOak Capital ESG Best-In-Class Strategy Fund Direct-Growth
0.58%
1006
0.22%
0.26%
ICICI Prudential Nifty Midcap 150 Index Fund Direct - Growth
0.33%
579
0.02%
0.07%
Navi Nifty Midcap 150 Index Fund Direct - Growth
0.34%
471
0.03%
0.08%
HDFC NIFTY Midcap 150 Index Fund Direct - Growth
0.34%
452
0.03%
0.08%
Zerodha Nifty Large Midcap 250 Index Fund Direct - Growth
0.17%
434
0.01%
0.04%
SBI Nifty Midcap 150 Index Fund Direct - Growth
0.34%
420
0.03%
0.08%
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
1.96%
389
0.17%
0.34%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.25%
-260
0.01%
0.05%
Aditya Birla Sun Life Nifty Midcap 150 Index Fund Direct-Growth
0.34%
246
0.02%
0.07%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.06%
208
0.00%
0.01%

About Global Health

Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Listing Date
16 Nov, 2022(2 Years, 43 days)
Chairperson NameNaresh Kumar Trehan